172 results on '"Ahrendt, Gretchen M"'
Search Results
2. ASO Visual Abstract: Changes in Surgical Management of the Axilla Over 11 Years—Report on Over 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial
3. Standardization of nodal radiation therapy through changes to a breast cancer clinical pathway throughout a large, integrated cancer center network
4. Magee Equation 3 predicts pathologic response to neoadjuvant systemic chemotherapy in estrogen receptor positive, HER2 negative/equivocal breast tumors
5. “Should I Stay Or Should I Go”: Second Opinion Retention In Breast Cancer Care At A Large Metro Healthcare System
6. Abstract P6-05-58: Comparing Patient-Reported Outcomes for Same-day Discharge and Inpatient Admission After Mastectomy
7. Axillary Lymph Node Burden in Invasive Breast Cancer: A Comparison of the Predictive Value of Ultrasound-Guided Needle Biopsy and Sentinel Lymph Node Biopsy
8. Patterns of care for omission of radiation therapy for elderly women with early-stage breast cancer receiving hormonal therapy
9. High Distress Portends Worse Patient-Reported Outcomes Among Newly Diagnosed Breast Cancer Patients
10. Relationship Status and Operation Type Are Important Predictors of Sexual Well-Being After Breast Cancer Surgery
11. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes
12. Persistent Breast Pain Among Women With Histories of Breast-conserving Surgery for Breast Cancer Compared With Women Without Histories of Breast Surgery or Cancer
13. Developing in vitro models of human ductal carcinoma in situ from primary tissue explants
14. The Pen and the Scalpel: Effect of Diffusion of Information on Nonclinical Variations in Surgical Treatment
15. Semiquantitative hormone receptor level influences response to trastuzumab-containing neoadjuvant chemotherapy in HER2-positive breast cancer
16. A Call to Re-evaluate Receptor Status for Breast Cancer Patients after Neoadjuvant Chemotherapy
17. Characterizing Informational Needs in Breast Cancer Patients
18. Localizing High-Risk Lesions for Excisional Breast Biopsy: A Comparison Between Radioactive Seed Localization and Wire Localization
19. Patterns of Change in Cognitive Function With Anastrozole Therapy
20. Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: The ACOSOG Z1071 (Alliance) Clinical Trial
21. Comparative Effectiveness of Ductal Carcinoma In Situ Management and the Roles of Margins and Surgeons
22. Delays in Breast Cancer Diagnoses: Do Patients Have Higher Distress?
23. An Evaluation of Opioid Prescribing Preferences in Surgical Residents and Faculty at a Large Academic Medical Center
24. Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy: A single institutional experience with 359 cases
25. Persistent breast pain in post-surgery breast cancer survivors and women with no history of breast surgery or cancer: associations with pain catastrophizing, perceived breast cancer risk, breast cancer worry, and emotional distress
26. Neuropathic pain following breast cancer surgery: proposed classification and research update
27. Waiting Game: How Long Are Breast Cancer Patients Waiting for Definitive Diagnosis and Treatment?
28. Persistent breast pain in post-surgery breast cancer survivors and women with no history of breast surgery or cancer: associations with pain catastrophizing, perceived breast cancer risk, breast cancer worry, and emotional distress
29. Does breast tumor location influence success of sentinel lymph node biopsy?
30. Intra-abdominal sepsis impairs colonic reparative collagen synthesis
31. Is completion axillary lymph node dissection necessary in patients who are underrepresented in the ACOSOG Z0011 trial?
32. Low Estrogen Receptor (ER)–Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy
33. Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance)
34. Prognostic Significance of Modified Residual Disease in Breast and Nodes (mRDBN) Algorithm After Neoadjuvant Chemotherapy for Breast Cancer
35. Low estrogen receptor (ER) positive breast cancer and neoadjuvant systemic therapy (NAT): Is response similar to ER+ or to ER- disease?
36. Utilization of Magee equation 3 in ER-positive, HER2-negative/equivocal tumors to determine pathologic response to neoadjuvant therapy.
37. Mitotic index to predict breast cancer recurrence after neoadjuvant systemic therapy.
38. HER2 equivocal breast cancer and neoadjuvant therapy: Is response similar to HER2-positive or HER2-negative tumors?
39. Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0–T4, N1–N2) Who Receive Neoadjuvant Chemotherapy
40. Predictors of trajectories of cognitive change in women with breast cancer.
41. Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance)
42. Is nipple aspirate fluid (NAF) a reliable source to identify biomarkers in breast cancer? A feasibility study.
43. Abstract P2-01-02: Methods impacting the false negative rate of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4,N1-2) who receive neoadjuvant chemotherapy – Results from a prospective trial – ACOSOG Z1071 (Alliance)
44. Abstract P1-15-02: Utilization of hypofractionated radiation therapy for early stage breast cancer in women over 50 years of age
45. Radioactive Seed Localization Versus Wire Localization for Lumpectomies: A Comparison of Outcomes
46. Factors Affecting Sentinel Lymph Node Identification Rate After Neoadjuvant Chemotherapy for Breast Cancer Patients Enrolled in ACOSOG Z1071 (Alliance)
47. The Importance of Detection of Subclinical Lymphedema for the Prevention of Breast Cancer-Related Clinical Lymphedema after Axillary Lymph Node Dissection; A Prospective Observational Study
48. Tumor Biology Correlates With Rates of Breast-Conserving Surgery and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer
49. Patterns of care for omission of radiation therapy for elderly women with early-stage breast cancer receiving hormonal therapy.
50. Persistent pain following breast cancer surgery: A case-control study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.